Surveillance imaging following treatment of head and neck cancer

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Post-treatment surveillance is an important component in the treatment of head and neck cancers, especially as the proportion of human papilloma virus-positive cancers increases. Early detection of recurrences or second malignancies can increase success and minimize the toxicity of salvage treatment. Unfortunately, there are no consensus guidelines on the frequency and modality of post-treatment imaging. Computed tomography, ultrasound, magnetic resonance imaging and positron emission tomography-computed tomography (PET-CT) all have unique advantages and disadvantages when used as surveillance imaging. There is evidence that PET-CT may be the most sensitive of these modalities, but further research is needed to show an improvement in patient outcomes. Institutions will benefit most from a surveillance plan that is consistent and tailored to the individualized needs of their patients. This review focuses on the available evidence for different imaging modalities and general guidelines for developing an institution-specific practice pattern.

Original languageEnglish (US)
Pages (from-to)323-329
Number of pages7
JournalSeminars in Oncology
Volume44
Issue number5
DOIs
StatePublished - Oct 1 2017

Fingerprint

Head and Neck Neoplasms
Papillomaviridae
Guidelines
Salvage Therapy
Second Primary Neoplasms
Therapeutics
Tomography
Magnetic Resonance Imaging
Recurrence
Research
Neoplasms
Positron Emission Tomography Computed Tomography

Keywords

  • head and neck cancer
  • imaging
  • surveillance

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Surveillance imaging following treatment of head and neck cancer. / Zhao, Xiao; Rao, Shyam.

In: Seminars in Oncology, Vol. 44, No. 5, 01.10.2017, p. 323-329.

Research output: Contribution to journalReview article

@article{2cb5512665724a4a95d64cb43ae525c7,
title = "Surveillance imaging following treatment of head and neck cancer",
abstract = "Post-treatment surveillance is an important component in the treatment of head and neck cancers, especially as the proportion of human papilloma virus-positive cancers increases. Early detection of recurrences or second malignancies can increase success and minimize the toxicity of salvage treatment. Unfortunately, there are no consensus guidelines on the frequency and modality of post-treatment imaging. Computed tomography, ultrasound, magnetic resonance imaging and positron emission tomography-computed tomography (PET-CT) all have unique advantages and disadvantages when used as surveillance imaging. There is evidence that PET-CT may be the most sensitive of these modalities, but further research is needed to show an improvement in patient outcomes. Institutions will benefit most from a surveillance plan that is consistent and tailored to the individualized needs of their patients. This review focuses on the available evidence for different imaging modalities and general guidelines for developing an institution-specific practice pattern.",
keywords = "head and neck cancer, imaging, surveillance",
author = "Xiao Zhao and Shyam Rao",
year = "2017",
month = "10",
day = "1",
doi = "10.1053/j.seminoncol.2018.01.010",
language = "English (US)",
volume = "44",
pages = "323--329",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Surveillance imaging following treatment of head and neck cancer

AU - Zhao, Xiao

AU - Rao, Shyam

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Post-treatment surveillance is an important component in the treatment of head and neck cancers, especially as the proportion of human papilloma virus-positive cancers increases. Early detection of recurrences or second malignancies can increase success and minimize the toxicity of salvage treatment. Unfortunately, there are no consensus guidelines on the frequency and modality of post-treatment imaging. Computed tomography, ultrasound, magnetic resonance imaging and positron emission tomography-computed tomography (PET-CT) all have unique advantages and disadvantages when used as surveillance imaging. There is evidence that PET-CT may be the most sensitive of these modalities, but further research is needed to show an improvement in patient outcomes. Institutions will benefit most from a surveillance plan that is consistent and tailored to the individualized needs of their patients. This review focuses on the available evidence for different imaging modalities and general guidelines for developing an institution-specific practice pattern.

AB - Post-treatment surveillance is an important component in the treatment of head and neck cancers, especially as the proportion of human papilloma virus-positive cancers increases. Early detection of recurrences or second malignancies can increase success and minimize the toxicity of salvage treatment. Unfortunately, there are no consensus guidelines on the frequency and modality of post-treatment imaging. Computed tomography, ultrasound, magnetic resonance imaging and positron emission tomography-computed tomography (PET-CT) all have unique advantages and disadvantages when used as surveillance imaging. There is evidence that PET-CT may be the most sensitive of these modalities, but further research is needed to show an improvement in patient outcomes. Institutions will benefit most from a surveillance plan that is consistent and tailored to the individualized needs of their patients. This review focuses on the available evidence for different imaging modalities and general guidelines for developing an institution-specific practice pattern.

KW - head and neck cancer

KW - imaging

KW - surveillance

UR - http://www.scopus.com/inward/record.url?scp=85042561115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042561115&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2018.01.010

DO - 10.1053/j.seminoncol.2018.01.010

M3 - Review article

C2 - 29580434

AN - SCOPUS:85042561115

VL - 44

SP - 323

EP - 329

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 5

ER -